Athira Pharma, Inc. (ATHA)
$4.79+1.48%Close
SELLCRISIS · day 15
Key stats
- Market cap
- $19M
- Beta
- 2.80
- P/E (TTM)
- -0.29
- 1W
- +1.70%
- 1M
- -31.08%
- vs SPY 1W
- +0.54%
- vs SPY 1M
- -34.07%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATHA?
- LOPJLB’s latest quantitative signal on Athira Pharma, Inc. (ATHA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ATHA in?
- Athira Pharma, Inc. (ATHA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Athira Pharma, Inc. (ATHA) do?
- Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound…